Corporate action official notices

Short Mini Future auf ThyssenKrupp AG

CH1188181882

Strike/Barrier Adjustments SG - 04.03.2025

The following strike/barrier adjustments were made:

10.03% p.a. Multi Barrier Reverse Convertible on EMS-Chemie, Nvidia, Sika, Tesla

CH1372398490

10.28% p.a. Multi Barrier Reverse Convertible on Apple, Meta Platforms, Microsoft, Nvidia, Tesla

CH1372398524

20.40% p.a. Multi Barrier Reverse Convertible on Air France - KLM, Carnival Corporation, TUI

CH1336240036

21Shares AG: Termination Notice for the ETP 21Shares Fantom ETP (AFTM)

CH1168929078

The Board of Directors of the Company (the “Board”) took note of the transition from the Underlying of the Affected Products, Fantom (FTM), to Sonic (S) with bidirectional swaps only possible until 18 March 2025. Due to insufficient service provider support for Sonic (S), transitioning the Underlying of the Affected Products from Fantom (FTM) to Sonic (S) is not feasible. The Affected Product tracks the performance of Fantom (FTM). Fantom (FTM) is currently undergoing a transition to Sonic (S), with Sonic (S) having been launched on 18 December 2024. While Fantom (FTM) holders will be able to switch to Sonic (S) on a 1:1 basis for six months after the launch of Sonic (S), bidirectional swaps will only be possible until 18 March 2025. At this time, not all service providers do yet support the infrastructure required for a smooth transition from Fantom (FTM) to Sonic (S) and are not able to provide this infrastructure in a reasonable timeframe that considers the interests of the investors. As a result, 21Shares AG cannot guarantee sufficient liquidity in its Affected Product after 18 March 2025. Therefore, based on Condition 5.1 (Termination and Redemption of Products by the Issuer), 21Shares AG hereby gives this Termination Notice. Pursuant to Condition 5.1 of the General Terms and Conditions for the ETPs, including the Affected Products, the Issuer may terminate and redeem the ETPs outstanding in any Series in whole but not in part at any time, at the Issuer’s sole discretion and without any further consent of or approval by the Investors. The Issuer has decided to terminate and redeem the Affected Products in accordance with its Conditions by payment of the Redemption Amount to the Global Paying Agent with effect as of Monday, 10 March 2025. The last trading day of the Affected Products will be Monday, 3 March 2025, with the Affected Products being delisted after market close as per 3 March 2025 from each exchange where the Affected Products are listed. The last date for creations and redemptions between the Authorized Participants and the Issuer will be Tuesday, 4 March 2025. Final Fixing Date The Final Fixing Date, i.e. the date for the determination of the Redemption Amount, will be Thursday, 6 March 2025. Redemption Date The Redemption Date, in accordance with its Conditions by payment of the Redemption Amount to the Global Paying Agent and payment through the clearing systems, will be Monday, 10 March 2025. Investors do not have to take any action, as the Redemption Amount from the sale of the Fantom (FTM) Underlying will be automatically credited to their accounts. However, they should keep in mind the ongoing transition to Sonic (S). While a 1:1 bidirectional switch is possible until 18 March 2025, as announced by the foundation, there is the possibility that the prices of Fantom (FTM) and Sonic (S) will differ significantly in the meanwhile due to lack of arbitrageurs. As the Affected Product follows the price of Fantom (FTM), 21Shares AG cannot not guarantee that the Fantom (FTM) price on the Final Fixing Date will be the same as the price of Sonic (S) and will therefore determine the Redemption Amount on a best effort basis in line with the Fantom (FTM) price and in accordance with the formula set out in the Final Terms applicable to the Affected Product (see below at "Redemption Amount"). Investors holding the Affected Product, including those who wish to follow the price of Sonic (S) rather than the one of Fantom (FTM), will be able to trade/sell the Affected Product until the last trading day on BX Swiss and Euronext Amsterdam and Paris (see "Termination Notice" above). Investors may experience a delay until their respective Redemption Amount is received by their financial service provider where their Affected Products are credited. Redemption Amount As per the terms and conditions of the Affected Products, the Redemption Amounts will be calculated in accordance with the formula set out in the applicable Final Terms. Given the ongoing transition from Fantom (FTM) to Sonic (S), the price used for the calculation of the redemption amount may differ from the price of the Underlying Fantom (FTM) on the Final Fixing Date. The Issuer will determine the Redemption Amount on a best effort basis, meaning they will try to minimize the impact of factors associated with the ongoing transition including, but not limited to, liquidity constraints and execution slippage. The Redemption Amounts will be announced on Friday, 7 March 2025.

Leonteq Securities AG - Delisting am Primärmarkt (Sponsored Segment)

US2908464017

Beschrieb: Aufhebung der Zulassung zum Handel aufgrund eines Delistings am Primärmarkt. Kontakt: David Haab, Leonteq Securities AG, Europaallee 39, 8004 Zürich Telefon: E-Mail: david.haab@leonteq.com Letzter Handelstag: 03.03.2025 Datum der Veröffentlichung: 28.02.2025 Für die folgenden Instrumente wird die Zulassung zum Handel aufgehoben (Sponsored Share): ISIN: US2908464017 Name: EMCORE Corp

Leonteq Securities AG - Early Redemptions

CH1369858597

Reason for the redemption: Issuer call Effective from: 3 March 2025 Publication as of: 4 March 2025

Nikola Corp

US6541103031

Short Mini Future auf Anheuser Busch InBev SA

CH1405806519

Short Mini Future auf Bayerische Motoren Werke AG

CH1381544464

Short Mini Future auf Fresenius SE & Co KGaA

CH1405809000

Short Mini Future auf Johnson & Johnson

CH1405809059

Short Mini Future auf Volkswagen AG

CH1381544589

Strike/Barrier Adjustment SG - 03.03.2025

The following strike/barrier adjustments were made:

Karyopharm Therapeutics Inc

US48576U1060

Long Mini Future auf Coinbase Global Inc

CH1405809182

Roche Finance 25

XS1195056079

Short Mini Future auf Bayer AG

CH1405807616

Thyssenkrupp 25

DE000A14J587

21Shares AG - Announcement regarding changes to the board of Directors of the Company

diverse

We are pleased to announce the following changes to the board of Directors of the Company effective as of 1 March 2025 ● The appointment of Russell Barlow as chairman of the board of directors and Chief Executive Officer ("CEO"); ● The appointment of Duncan Moir as a member of the board of directors and President. ● The appointment of Edel Bashir as a member of the board of directors and Chief Operating Officer ("COO").

6.32% p.a. Multi Barrier Reverse Convertible on Richemont, Nestlé, Novartis, Roche, UBS

CH1409724270

Basler Kantonalbank - Early Redemptions

CH1318756751, CH1318756769

Reason for the redemption: Issuer call Effective from: 28 February 2025 Publication as of: 3 March 2025

Capital Protection Certificate with Barrier on Nestlé, Novartis, Roche

CH1409724338

Leonteq Securities AG - Delisting am Primärmarkt (Sponsored Segment)

US45667G1031

Beschrieb: Aufhebung der Zulassung zum Handel aufgrund eines Delistings am Primärmarkt. Kontakt: David Haab, Leonteq Securities AG, Europaallee 39, 8004 Zürich Telefon: E-Mail: david.haab@leonteq.com Letzter Handelstag: 28.02.2025 Datum der Veröffentlichung: 28.02.2025 Für die folgenden Instrumente wird die Zulassung zum Handel aufgehoben (Sponsored Share): ISIN: US45667G1031 Name: Infinera Corp